Category: Fair Value

Itron, Inc. receives a lower fair value.

MGP Ingredients and Triumph Grp move up in Fair value while Eagle Pharmaceuticals, ICU Medical, Meredith Corp, and Symantec Corp all decline.

Energen, Ennata Pharmaceuticals, Hain Celestial, Gartner, Jones Lang LaSalle, McDermott Intl all receive increases in fair value while Cohu, and Mallinckrodt Plc drop.

Five earn higher fair values, three decline

Overvaluation pressures have moved valuations back to mid-teens / low-twenties while market returns have been lackluster. U.S. AllCap return, year-to-date, is flat at (0.57)% giving credibility to the point that investor expectations are still positive, but not as euphoric as earlier in the year when valuations were in the high twenties. LargeCap has moved up the most, 5.0 percentage points, followed by MidCap advancement of 2.2 points followed by SmallCap with an increase of 1.7 points. It is interesting that SmallCap is the leader in gains so far this year at 1.76%